Clinical Trial Update: Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of adjuvant cetuximab with chemoradiation in head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Chemoradiation therapy (chemoradiation therapy)
• ERBITUX (cetuximab)

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED